Gonorrhea Treatment in Patients with Penicillin Allergy
For patients with penicillin allergy requiring gonorrhea treatment, use ceftriaxone 250 mg intramuscularly as a single dose plus azithromycin 1 g orally, as cephalosporins can be safely administered to most penicillin-allergic patients due to low cross-reactivity (approximately 1-3%). 1, 2
Primary Treatment Approach
The standard gonorrhea regimen remains appropriate for most penicillin-allergic patients because:
- Ceftriaxone is a cephalosporin, not a penicillin, and true cross-reactivity between penicillins and third-generation cephalosporins is rare 3
- The recommended regimen is ceftriaxone 125-250 mg intramuscularly plus azithromycin 1 g orally as a single dose 3, 1
- This dual therapy addresses both gonorrhea and presumptive chlamydial co-infection 3, 2
For Severe Cephalosporin Allergy
If the patient has a documented severe cephalosporin allergy or anaphylaxis to beta-lactams:
Use azithromycin 2 g orally as a single dose 1, 2
Critical Requirements with Azithromycin Monotherapy:
- Perform test-of-cure 1 week after treatment using culture (preferred) or NAAT 1, 2
- Culture is preferred because it allows antimicrobial susceptibility testing 1, 2
- Consult an infectious disease specialist due to limited data on alternative regimens 2
- Report suspected treatment failures to local public health officials within 24 hours 1, 2
Important Caveats About Azithromycin:
- Gastrointestinal adverse events are common with the 2 g dose 4
- Resistance concerns exist, particularly in certain geographic areas 5
- Azithromycin 1 g is insufficient as monotherapy and should not be used 3
Additional Alternative Regimens
For uncomplicated urogenital and anorectal infections when cephalosporins cannot be used:
- Spectinomycin 2 g intramuscularly as a single dose (cure rate 98.2%) 1
- Gentamicin 240 mg intramuscularly plus azithromycin 2 g orally (100% cure rate in clinical trials) 4
- Gemifloxacin 320 mg orally plus azithromycin 2 g orally (99.5% cure rate) 4
Critical Limitation of Spectinomycin:
- Only 52% effective against pharyngeal gonorrhea 3, 1
- Requires pharyngeal culture 3-5 days post-treatment if pharyngeal infection suspected 3
Quinolone Considerations
Quinolones should NOT be routinely used due to widespread resistance 3
Only consider quinolones if:
- Antimicrobial susceptibility testing confirms susceptibility 1
- Options include ciprofloxacin 500 mg orally or levofloxacin 250 mg orally 3
Site-Specific Treatment Considerations
Pharyngeal Gonorrhea:
- More difficult to eradicate than urogenital infections 3, 1
- Ceftriaxone remains most effective 3
- Spectinomycin is inadequate (52% efficacy) 3, 1
- Gentamicin/azithromycin cured 10/10 pharyngeal infections in trials 4
- Gemifloxacin/azithromycin cured 15/15 pharyngeal infections 4
Disseminated Gonococcal Infection:
- Ceftriaxone 1 g IM/IV daily for ≥1 week 3
- Alternative: Spectinomycin 2 g IM every 12 hours for ≥1 week 3
Gonococcal Conjunctivitis:
Essential Management Steps
Partner Management:
- Evaluate and treat all sex partners from preceding 60 days 1, 2
- Patients must avoid sexual intercourse until therapy completed and both partners asymptomatic 1, 2
- Consider expedited partner therapy if partner treatment cannot be ensured 2
Co-infection Treatment:
- Always treat presumptively for chlamydia unless ruled out 3, 2
- Use azithromycin 1 g orally or doxycycline 100 mg orally twice daily for 7 days 3
Follow-up Testing:
- Test-of-cure required only for alternative regimens (not standard ceftriaxone) 3
- Retest all patients at 3 months due to high reinfection rates 3
- If 3-month follow-up unlikely, retest whenever patient returns within 12 months 3
Special Populations
Pregnancy:
- Pregnant women with penicillin allergy should receive ceftriaxone (cross-reactivity risk is acceptable) 3
- Spectinomycin 2 g intramuscularly is alternative if cephalosporin absolutely contraindicated 3
- Never use doxycycline, quinolones, or tetracyclines in pregnancy 3, 2
- For chlamydia co-treatment: use erythromycin or amoxicillin 3, 2
HIV-Infected Patients:
- Use same treatment regimens as HIV-negative patients 3
- Exercise caution with alternative regimens as data are limited 3
Common Pitfalls to Avoid
- Do not assume penicillin allergy precludes cephalosporin use—most patients can safely receive ceftriaxone 1, 2
- Do not use azithromycin 1 g as monotherapy—insufficient efficacy 3
- Do not use quinolones without susceptibility testing—resistance is widespread 3, 1
- Do not forget test-of-cure with alternative regimens—treatment failure monitoring is essential 1, 2
- Do not neglect chlamydia co-treatment—co-infection rates are high 3, 2